Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… CHLOROTHIAZIDE Suspension; 250MG/5ML DIURIL MERCK 011145 CHLOROTHIAZIDE Tablet; 250MG DIURIL MERCK 011145 CHLOROTHIAZIDE Tablet; 500MG DIURIL MERCK 084388 CHLOROTHIAZIDE Tablet; 250MG CHLOROTHIAZIDE Mylan 084217 CHLOROTHIAZIDE Tablet; 500MG CHLOROTHIAZIDE Mylan 086028 CHLOROTHIAZIDE Tablet; 250MG CHLOROTHIAZIDE West Ward 087736 CHLOROTHIAZIDE Tablet; 500MG CHLOROTHIAZIDE West Ward 011145 CHLOROTHIAZIDE SODIUM Injection 500MG BASE/VIAL DIURIL MERCK 011635 BP CHLOROTHIAZIDE; RESERPINE Tablet; 250MG;0.125MG DIUPRES-250 MERCK 011635 BP CHLOROTHIAZIDE; RESERPINE Tablet; 500MG;0.125MG DIUPRES-500 | Diuril (chlorothiazide) Intravenous Injection Merck & Co., Inc, Labeling Revision | Diuril (chlorothiazide) Oral Suspension Merck & Co., Inc, Labeling Revision | Diuril (chlorothiazide) Tablets Merck & Co., Inc, Labeling Revision | Diruil (chlorothiazide) intravenous Injection and tablets, Merck & Co., Labeling Revision | Diuril (chlorothiazide) Tablets, Merck & Co., Labeling Revision | Diuril (chlorothiazide) Suspension, Merck & Co., Labeling Revision | Diuril Chlorothiazide Oral Suspension, Salix Pharma, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com